Home By PE Sector Buyout UPDATED – KKR confirms full exit from Gland Pharma to China’s Fosun...

UPDATED – KKR confirms full exit from Gland Pharma to China’s Fosun for $1.26bn

By

Vanya Damyanova

-

July 28, 2016

1024

Global private equity group KKR has confirmed the sale of its stake in India’s Gland Pharma to Shanghai Fosun Pha

Technology partner